NCT04898647
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- CHU Amiens Amiens, France
Clinical trial condition
Waldenstrom Macroglobulinemia
Explore clinical trials studying Waldenstrom Macroglobulinemia. Study availability and eligibility vary by location and protocol.
107 public trials
23 recruiting studies
Waldenstrom Macroglobulinemia trial results
NCT05914662
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China
NCT04061512
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Royal United Hospital, Bath Bath, United Kingdom
- The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust Bournemouth, United Kingdom
- East Kent Hospitals University NHS Foundation Trust Canterbury, United Kingdom
- University Hospital of Wales Cardiff, United Kingdom
Not Yet Recruiting
Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy
NCT07711327
- Conditions
- Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Fibrillation (AF), +35 more
- Locations
-
- City of Hope Duarte, California, United States
- UC San Diego Health San Diego, California, United States
- Stanford Health Care Stanford, California, United States
Not Yet Recruiting
Mosunetuzumab in Combination With Pirtobrutinib in Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia (MPOWER)
NCT07548450
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States
Not Yet Recruiting
Nemtabrutinib, Bortezomib, and Rituximab for WM
NCT07464210
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
Not Yet Recruiting
Study Evaluating the Efficacy and Tolerance of a Zanubrutinib and BGB-11417 Combination in Patients Previously Treated for Waldenström Macroglobulinemia
NCT06547866
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- AMIENS - CH Amiens Picardie Site Sud Amiens, France
- Angers Chu Angers, France
- ANNECY - CH Annecy Genevois Annecy, France
- ARGENTEUIL - Centre hospitalier Victor Dupouy Argenteuil, France
Not Yet Recruiting
Establishment of Genomic, Transcriptomic and Functional Characteristics of Tumor Cells in Hyperinflammatory Hemopathies
NCT04702932
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- Service de Médecine Interne Paris, France
NCT05024045
- Conditions
- B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +29 more
- Locations
-
- The University of Arizona Cancer Center Tucson, Arizona, United States
- City of Hope National Medical Center Duarte, California, United States
- University of California San Francisco, Medical Center at Paranassus San Francisco, California, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
NCT02332980
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +48 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States